Profil
Elizabeth Homans is currently the Chief Executive Officer at Immulus, Inc. and also serves as the Director at Delfi Diagnostics, Inc. She was previously the Chief Executive Officer & Director at Lyell Immunopharma, Inc. and Executive Director-Project Leadership at Jazz Pharmaceuticals, Inc. Ms. Homans holds an MBA from The Trustees of Columbia University in The City of New York and an undergraduate degree from Bates College.
Postes actifs de Elizabeth Homans
| Sociétés | Poste | Début |
|---|---|---|
Immulus, Inc.
Immulus, Inc. Pharmaceuticals: MajorHealth Technology Manufactures cell therapies | Directeur Général | - |
Delfi Diagnostics, Inc.
Delfi Diagnostics, Inc. BiotechnologyHealth Technology Develops AI-powered liquid biopsy tests using fragment omics technology to help detect cancer early through simple blood draws | Directeur/Membre du Conseil | 30/03/2022 |
Anciens postes connus de Elizabeth Homans
| Sociétés | Poste | Fin |
|---|---|---|
| LYELL IMMUNOPHARMA, INC. | Directeur Général | 15/12/2022 |
Jazz Pharmaceuticals, Inc.
Jazz Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceutical products | Corporate Officer/Principal | 01/11/2007 |
Formation de Elizabeth Homans
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Jazz Pharmaceuticals, Inc.
Jazz Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceutical products | Health Technology |
The Trustees of Columbia University in The City of New York
The Trustees of Columbia University in The City of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bates College
Bates College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Lyell Immunopharma, Inc.
Lyell Immunopharma, Inc. BiotechnologyHealth Technology Develops cell-based immunotherapies for human diseases | Health Technology |
Delfi Diagnostics, Inc.
Delfi Diagnostics, Inc. BiotechnologyHealth Technology Develops AI-powered liquid biopsy tests using fragment omics technology to help detect cancer early through simple blood draws | Health Technology |
Immulus, Inc.
Immulus, Inc. Pharmaceuticals: MajorHealth Technology Manufactures cell therapies | Health Technology |
















